Ming Sun
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in ⓘ
-
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Shu Wang (4 shared papers)Shufang Nie (4 shared papers)Naïma Moustaïd‐Moussa (2 shared papers)Jia Zhang (2 shared papers)Dayong Wu (1 shared paper)Rui Su (1 shared paper)Wenyan Zhao (7 shared papers)Xuan Pan (1 shared paper)
- Journals
- Surgical Oncology (2 papers)Artificial Organs (2 papers)Chemical Communications (1 paper)Bioelectrochemistry (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ming Sun
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 131
- Molecular Medicine 138
- Biochemistry 153
- Pharmaceutical Science 118
- Complementary and alternative medicine 122
- Biomaterials 181
Countries citing papers authored by Ming Sun
This map shows the geographic impact of Ming Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Sun more than expected).
Fields of papers citing papers by Ming Sun
This network shows the impact of papers produced by Ming Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Sun. The network helps show where Ming Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 369 | |
| 2 | 2013 | 197 | |
| 3 | 2020 | 140 | |
| 4 | 2013 | 102 | |
| 5 | 2018 | 58 | |
| 6 | 2007 | 48 | |
| 7 | 2014 | 47 | |
| 8 | 2019 | 42 | |
| 9 | 2017 | 38 | |
| 10 | 2021 | 37 | |
| 11 | 2011 | 34 | |
| 12 | 2023 | 34 | |
| 13 | 2016 | 29 | |
| 14 | 2020 | 26 | |
| 15 | 2012 | 23 | |
| 16 | 2009 | 22 | |
| 17 | 2015 | 21 | |
| 18 | Withaferin-A induces apoptosis in osteosarcoma U2OS cell line via generation of ROS and disruption of mitochondrial membrane potential. | 2017 | 20 |
| 19 | 2018 | 18 | |
| 20 | 2022 | 16 |
About Ming Sun
Ming Sun is a scholar working on Cancer Research, Molecular Medicine, Complementary and alternative medicine, Biochemistry and Biomaterials, having authored 53 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer, Lipids, and Metabolism (2 papers), Advanced X-ray and CT Imaging (2 papers), Polysaccharides and Plant Cell Walls (2 papers) and Ginseng Biological Effects and Applications (2 papers). The work is most often cited by research in Molecular Medicine (138 citations), Biochemistry (153 citations), Pharmaceutical Science (118 citations), Complementary and alternative medicine (122 citations) and Biomaterials (181 citations). Ming Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shu Wang, Shufang Nie, Naïma Moustaïd‐Moussa, Jia Zhang, Dayong Wu, Rui Su, Wenyan Zhao, Xuan Pan, Zhaoyang Fan and Ruiwen Zhang. Their work appears in journals such as Surgical Oncology, Artificial Organs, Chemical Communications, Bioelectrochemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.